the Next Generation Molecular Test For Prostate Cancer Trademark Details

The Next Generation Molecular Test for Prostate Cancer was registered on Tuesday, September 11, 2007 and is currently owned by Bostwick Laboratories, Inc. under the registration number 3290966 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Thursday, March 20, 2014, according to the United State Patent & Trademark Office
Word Mark The Next Generation Molecular Test for Prostate Cancer
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Bostwick Laboratories, Inc. of Glen Allen, VA

View all trademarks for Bostwick Laboratories, Inc.
Other Trademarks for Bostwick Laboratories, Inc.
Serial Number 78935987
Registration Number 3290966
Status Date Thursday, March 20, 2014
Filing Date Thursday, March 20, 2014
Registration Date Tuesday, September 11, 2007
Attorney E. Scott Johnson, Esq.

Correspondent

E. Scott Johnson, Esq.
Ober, Kaler, Grimes & Shriver, A Profess
100 Light Street
Baltimore MD 21202

Case File Statements

Disclaimer with Predetermined Text "Molecular Test for Prostate Cancer"
Goods & Services Healthcare and Medical Services, Namely, Medical Pathology Services for the Diagnosis and Treatment of Diseases

Classifications

International Class Codes
044 — Class 44 includes mainly medical care, hygienic and beauty care given by persons or establishments to human beings and animals; it also includes services relating to the fields of agriculture, horticulture and forestry.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, July 28, 2006
First Use Anywhere Thursday, May 4, 2006
First Use In Commerce Thursday, May 11, 2006
Primary Code 044

You must be signed in to print.

Once signed in, look for the PDF button.